tradingkey.logo
tradingkey.logo

Merck Nears $6 Billion All-Cash Deal to Buy Terns Pharma

ReutersMar 25, 2026 1:12 AM

March 24 (Reuters) - Merck MRK.N is nearing a roughly $6 billion all-cash deal to buy biotech firm Terns Pharma TERN.O, the Financial Times reported on Tuesday, citing people familiar with the matter.

Talks between Merck and Terns were at an advanced stage and a deal could be reached in the coming days, the report added.

Merck and Terns Pharma did not immediately respond to Reuters' request for comment.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI